3201 - 3210 of 8571 Results
Title
Year
- O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s disease2017OPENTitle: O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s diseaseJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-017-0311-1Best OA location URL: https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-017-0311-1Citation Count: 81
- A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalography2021OPENTitle: A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalographyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-99167-2Best OA location URL: https://www.nature.com/articles/s41598-021-99167-2.pdfCitation Count: 3
- Mitochondrial and Endoplasmic Reticulum Stress Trigger Triglyceride Accumulation in Models of Parkinson’s Disease Independent of Mutations in MAPT2023OPENTitle: Mitochondrial and Endoplasmic Reticulum Stress Trigger Triglyceride Accumulation in Models of Parkinson’s Disease Independent of Mutations in MAPTJournal Name: MetabolitesPublisher: MDPI AGVol: 13Issue #: 1Start Page: 112End Page: 112Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/metabo13010112Best OA location URL: https://www.mdpi.com/2218-1989/13/1/112/pdf?version=1673484935Citation Count: 6
- Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains2010OPENTitle: Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brainsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 1Start Page: 27End Page: 36Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23442Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6333467Citation Count: 167
- Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)2023OPENTitle: Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00533-wBest OA location URL: https://www.nature.com/articles/s41531-023-00533-w.pdfCitation Count: 18
- A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography2015RESTRICTEDTitle: A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomographyJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 12Start Page: 1692End Page: 1695Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26411Citation Count: 23
- Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing2019OPENTitle: Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencingJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0873-5Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0873-5Citation Count: 41
- Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson’s disease2020OPENTitle: Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson’s diseaseJournal Name: Cytokine: XPublisher: Elsevier BVVol: 2Issue #: 2Start Page: 100027End Page: 100027Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cytox.2020.100027Best OA location URL: https://doi.org/10.1016/j.cytox.2020.100027Citation Count: 40
- Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease2020OPENTitle: Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 72Issue #:Start Page: 7End Page: 12Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.01.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7179075Citation Count: 59
-
OPENTitle: Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and AnalogsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 1Start Page: 119End Page: 135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00597Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10147382Citation Count: 46